Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c

Abstract

Purpose

Regarding the role of inflammation in progression of diabetes this study was conducted to investigate the association between inflammatory biomarkers such as nitric oxide (NO), tumor necrosis factor alpha (TNF-α), and high-sensitivity C-reactive protein (hs-CRP) with the chance of existence of diabetic retinopathy and its progression in patients with diabetes.

Methods

A total of 83 patients with T2DM (Type 2 diabetes mellitus) were divided into three groups of patients with proliferative diabetic retinopathy (PDR), patients with non-proliferative diabetic retinopathy (NPDR) and patients without diabetic retinopathy (NDR) based on ophthalmologic funduscopic examination. Twenty six healthy controls were also enrolled. Blood samples were taken after 12 h of overnight fasting, NO, TNF-α, and hs-CRP were measured. Association of the level of these biomarkers with retinopathy was analyzed.

Results

The levels of TNF-α, NO and hs-CRP were higher among patients with diabetic retinopathy. Multinomial Logistic Regression model showed that TNF-α and NO could predict the presence of retinopathy among patients with diabetes when adjusted for hs-CRP, HbA1c, FBS, gender, total cholesterol, triglyceride, HDL, LDL, BMI, and age (respectively OR = 1.76, CI 95% = 1.01–3.02, p = 0.046 and OR = 1.12, CI 95% = 1.05–1.18, p < 0.001); however they could not predict the severity of retinopathy. In ROC analysis AUC for TNFα was 0.849 (p < 0.001) and for NO was 0.907 (p < 0.001). Serum TNF-α level of 7.10 pmol/L could be suggestive of the presence of retinopathy (sensitivity = 92.2% and specificity = 66.0%), also serum NO level of 45.96 μmol/L could be suggestive of the presence of retinopathy (sensitivity = 96.1% and specificity = 86%).

Conclusions

Our results suggest elevated levels of NO and TNF-α can be suggestive of diabetic retinopathy.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Y. Behl et al. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am. J. Pathol. 172(5), 1411–1418 (2008)

    Article  Google Scholar 

  2. 2.

    M.V. van Hecke et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 48(7), 1300–1306 (2005)

    CAS  Article  Google Scholar 

  3. 3.

    A.M. Spijkerman et al. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med. 24(9), 969–976 (2007)

    CAS  Article  Google Scholar 

  4. 4.

    T.S. Kern, Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007, 95103 (2007)

    Article  Google Scholar 

  5. 5.

    K. Zorena et al. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Med. Inflamm. 2007, 92196–92196 (2007)

    Article  Google Scholar 

  6. 6.

    D. Ray et al. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53(3), 861 (2004)

    CAS  Article  Google Scholar 

  7. 7.

    A.M. Joussen et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 16(3), 438–440 (2002)

    CAS  Article  Google Scholar 

  8. 8.

    R. Arita et al. A key role for ROCK in TNF-α–mediated diabetic microvascular damage. Investig. Ophthalmol. Vis. Sci. 54(3), 2373–2383 (2013)

    Article  Google Scholar 

  9. 9.

    M. Torzewski et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20(9), 2094–2099 (2000)

    CAS  Article  Google Scholar 

  10. 10.

    A.R. Tall, C-reactive protein reassessed. N. Engl. J. Med. 350(14), 1450–1452 (2004)

    CAS  Article  Google Scholar 

  11. 11.

    J. Song et al. Relationship between C-reactive protein level and diabetic retinopathy: a systematic review and meta-analysis. PLoS ONE 10(12), e0144406 (2015)

    Article  Google Scholar 

  12. 12.

    W. Zhang et al. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy 3(5), 609–628 (2011)

    CAS  Article  Google Scholar 

  13. 13.

    Q. Li et al. Diabetic eNOS-knockout mice develop accelerated retinopathy. Investig. Ophthalmol. Vis. Sci. 51(10), 5240–5246 (2010)

    Article  Google Scholar 

  14. 14.

    A.M. Abu El-Asrar et al. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18(3), 306–313 (2004)

    CAS  Article  Google Scholar 

  15. 15.

    G.K. Kolluru, S.C. Bir, C.G. Kevil, Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 30 (2012)

    Google Scholar 

  16. 16.

    American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care, 42(Supplement 1), S13 (2019)

  17. 17.

    G.S. Hotamisligil, B.M. Spiegelman, Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43(11), 1271–1278 (1994)

    CAS  Article  Google Scholar 

  18. 18.

    G.S. Hotamisligil et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Investig. 95(5), 2409–2415 (1995)

    CAS  Article  Google Scholar 

  19. 19.

    P.A. Kern et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Investig. 95(5), 2111–2119 (1995)

    CAS  Article  Google Scholar 

  20. 20.

    P. Peraldi et al. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271(22), 13018–13022 (1996)

    CAS  Article  Google Scholar 

  21. 21.

    F. Balkwill, TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 25(3), 409–416 (2006)

    CAS  Article  Google Scholar 

  22. 22.

    M.J. Tisdale, Cancer cachexia. Langenbecks Arch. Surg. 389(4), 299–305. (2004)

    Article  Google Scholar 

  23. 23.

    A.M. Joussen et al. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol. Vis. 15, 1418–1428 (2009)

    CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    S. Doganay et al. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16(2), 163–170 (2002)

    CAS  Article  Google Scholar 

  25. 25.

    N. Makino et al. High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. J. Diabetes Complicat. 19(6), 347–355 (2005)

    Article  Google Scholar 

  26. 26.

    D.N. Koleva-Georgieva, N.P. Sivkova, D. Terzieva, Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Med. 53(2), 44–50 (2011)

    Google Scholar 

  27. 27.

    H. Kaneto et al. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44(7), 733–738 (1995)

    CAS  Article  Google Scholar 

  28. 28.

    M.L. McDaniel et al. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211(1), 24–32 (1996)

    CAS  Article  Google Scholar 

  29. 29.

    T.J. Guzik, R. Korbut, T. Adamek-Guzik, Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54(4), 469–487 (2003)

    CAS  PubMed  Google Scholar 

  30. 30.

    Z. Davoudi et al. Changing correlations among ADMA, NO and hs-CRP in normoalbuminuric and microalbuminuric patients with type 2 diabetes. Meta Gene 10, 95–99 (2016)

    Article  Google Scholar 

  31. 31.

    J.L. Wilkinson-Berka, Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr. Pharm. Des. 10(27), 3331–3348 (2004)

    CAS  Article  Google Scholar 

  32. 32.

    E.C. Leal et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 48(11), 5257–5265 (2007)

    Article  Google Scholar 

  33. 33.

    P.S. Chan, M. Kanwar, R.A. Kowluru, Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J. Diabetes Complicat. 24(1), 55–63 (2010)

    Article  Google Scholar 

  34. 34.

    M. Manju et al. Relationship between glycosylated hemoglobin, serum nitric oxide and mean arterial blood pressure. Int. J. Biomed. Sci. 10(4), 252–257 (2014)

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    A. Ghosh et al. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. Int. J. Appl. Basic Med. Res. 1(1), 31–35 (2011)

    CAS  Article  Google Scholar 

  36. 36.

    D. Tousoulis et al. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol. 10(1), 4–18 (2012)

    CAS  Article  Google Scholar 

  37. 37.

    A.M. El-Asrar, Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr. J. Ophthalmol. 19(1), 70–74 (2012)

    Article  Google Scholar 

  38. 38.

    T.S. Assmann et al. Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis. Nitric Oxide 61, 1–9 (2016)

    CAS  Article  Google Scholar 

  39. 39.

    A.N.N. Mertens, P. Holvoet, Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J. 15(12), 2073–2084 (2001)

    CAS  Article  Google Scholar 

Download references

Acknowledgements

Research is reported in this publication was supported by Elite Researcher Grant Committee under award number 963276 from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Manouchehr Nakhjavani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Khaloo, P., Qahremani, R., Rabizadeh, S. et al. Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c. Endocrine (2020). https://doi.org/10.1007/s12020-020-02353-x

Download citation

Keywords

  • Diabetic retinopathy
  • Type 2 diabetes
  • Inflammation
  • Nitric oxide
  • Tumor necrosis factor alpha
  • High-sensitivity C-reactive protein